On May 4, 2019, the "China Japan pharmaceutical care practice seminar", jointly sponsored by China Japan Medical Science and Technology Exchange Association, Japan Medical Association, medical knowledge management (MKM) special fund Expert Committee and other units, as an important sub forum of the "2019 Forbidden City International Pharmacist Forum", was successfully held in Jiuhua villa Conference Center. Professor Zhang Xianglin, executive director of Chinese Pharmacological Society and chairman of TDM special committee of Chinese Pharmacological Society, vice president of Japanese Hospital Pharmacist Association, Professor of Kagoshima University Hospital and Professor Takeda Taisheng, Minister of pharmacy, served as the Chinese and Japanese chairmen of this seminar respectively. Professor Takeda Taisheng, director of Pharmacy Department of Kanto Hospital of NTT East Japan and director of Pharmacy Department of Hebei General Hospital of Japan, Professor Yoshio Koei, vice president of Xiangya Hospital of Central South University Professor Gong Zhicheng, the leader of pharmaceutical discipline, delivered wonderful speeches respectively. Representatives of pharmaceutical workers from Japan and more than 50 excellent pharmaceutical workers from more than 20 provinces in China attended the meeting and actively participated in the discussion. The two sides discussed the practical exchange of pharmaceutical care between China and Japan, the training mechanism of pharmaceutical professionals, reasonable and safe infusion, the construction of information system In the face of aging social structure, medical reform measures and other topics were discussed in depth.

At the invitation of the host organization, Beijing Huawei pharmaceutical deeply participated in the seminar. Mr. Guan Qingwei, chairman, Ms. Yu Liang, general manager, Mr. Yu peitao, deputy general manager and Ms. Luo Xiaolan, marketing director attended the meeting.

Professor Zhang Xianglin, executive director of Chinese Pharmacological Society and chairman of TDM special committee of Chinese Pharmacological Society

At the beginning of the meeting, Professor Zhang Xianglin, the Chinese President of the conference, delivered a welcome speech to welcome you to participate in this China Japan pharmaceutical care practice seminar. Professor Zhang Xianglin first welcomed the Chinese guests: Ms. Jin Jinghua, Deputy Secretary General of China Japan Medical Science and Technology Exchange Association, Professor Gong Zhicheng, vice president of Xiangya Hospital of Central South University and leader of pharmacy, Mr. Guan Qingwei, chairman of Beijing Huawei Pharmaceutical Co., Ltd., Ms. Yu Liang, general manager, etc.

The chairman of the Japanese side, Professor Takeda Taisheng, delivered a speech and introduced the Japanese guests attending the meeting: Professor Yoshio Koizumi, director of the pharmacy department of NTT East Japan Kanto hospital and Hebei general hospital in Japan, Ms. Ma ChunZi, deputy director of the pharmacy department of Kagoshima University Hospital in Japan, Dr. takefan Yucheng, President of the board of directors of kusurinomidori pharmacy, and Mr. Li Kawasaki, consultant of China Japan Medical Science and Technology Exchange Association. Professor Takeda Taisheng said that since the initial period of the international Pharmacist Forum in the Forbidden City, the session of Japanese pharmacists has been actively involved. The exchanges between the two sides have a long history. It is expected that in the "Linghe" era just begun in Japan, Chinese and Japanese pharmacists can communicate and cooperate more deeply and widely.

As a special guest of the Forbidden City International Pharmacist Forum, Professor Koizumi also delivered a speech at the forum, thanking the invitation of the Forbidden City Pharmacist Forum and the support of Beijing Huawei medicine for the forum.

Professor Gong Zhicheng, vice president of Xiangya Hospital of Central South University and leader of pharmacy

  Professor Gong Zhicheng delivered a keynote speech entitled "the attempt of infusion as the entry point of rational and safe drug use". Combined with the project of the monitoring and early warning information system platform of the combination of medicine, medicine and nursing and rational drug use being promoted by Xiangya Hospital, he analyzed the current situation of many daily work projects of the domestic pharmacy department, lack of operation specifications, difficult assessment and evaluation, low influence in the industry, the difficulties of various types of information platforms and difficult integration, and the difficulties of medical The urgent need of compound talents who are familiar with medicine and information. This paper analyzes in detail the differences in per capita infusion volume and the proportion of adverse events at home and abroad, shares the experience of Hunan regional safety evaluation center established under the leadership of Hunan Provincial Health Commission, and introduces the first reviewed medical care early warning monitoring system of Xiangya Hospital as a visual platform to help infusion safety. It is concluded that reasonable infusion seems to be a trivial matter, but it is actually a complex system engineering.

Professor Yoshio Koizumi, director of Pharmacy Department of NTT East Japan Kanto hospital and Hebei general hospital, Japan

  Professor Yoshio kinai delivered a keynote speech entitled "pharmaceutical information". Similar to Professor Gong Zhicheng, Professor kinai is also committed to promoting the construction of medical big data information system in Japan. It is proposed that about 5 million data from 10 hospitals in Japan can be incorporated into the system. The key to how to use flexibly and correctly is standardization. Practice shows that how to collect and analyze data has become the intelligence and knowledge of pharmacists and the industry, which is an important problem. Professor kinai has been involved in the construction of this platform in Japan for seven years before making the current progress. He is very interested in the system construction described by Professor Gong Zhicheng.

Professor Takeda Taisheng, vice president of Hospital Pharmacists Association of Japan, Professor of Kagoshima University Hospital and Minister of pharmacy

  Professor Takeda Taisheng expounded the development of pharmaceutical care in Japan from three aspects: 1. Talent training mode, 2. Practical ability training, 3. Business mode of pharmacies. Professor Takeda introduced the development process of pharmaceutical education in Japan from four-year system to six-year system, the business changes of pharmacists in Japanese hospitals from mainly focusing on preparations to serving patients, and the pharmacist qualification certification system in various sub fields. He explained it with the example of Kagoshima hospital, in order to cultivate pharmacists who can cooperate with doctors. In terms of national policies, Professor Takeda is also deeply involved in government decision-making. Because the medical insurance expenditure is too high and the social phenomenon of super old age is becoming more and more serious, the government is gradually promoting the separation of medicine. It is hoped that at present, 80% of Japan's 59000 pharmacies receive specific prescriptions in front of specific medical institutions. By 2025, residents will have relatively fixed "frequent pharmacies", and pharmacies will have senior pharmaceutical managers. By 2035, all front pharmacies will be cancelled and all pharmacies will be integrated into the community to cope with the increasingly serious society of super elderly. It is hoped that the drugstore can: 1. Fully grasp the situation of patients and give guidance; 2. Provide 24-hour family service; 3. Fully cooperate with medical institutions. Professor Zhang Xianglin expressed great support for Professor Takeda Taisheng's view that pharmacists should have no walls, be patient-centered and serve the whole society.

  As the supporting unit of this forum, Mr. Yu peitao, on behalf of the company, gave an introduction to the results of China Japan exchange of Beijing Huawei medicine, conveying the original intention of Huawei medicine to become an integrator, sharer and innovator in China's great health field, This paper introduces the work of Huawei pharmaceutical in the communication between China and Japan in the pharmaceutical industry, as well as the introduction of cefazolin sodium for injection / sodium chloride injection instant powder liquid double chamber bag and children's cephalosporin hydrochloride granules to improve China's medical level.

Discussion session photos

In the free communication link, Dr. takefan Yucheng, a Japanese guest, asked Professor Gong Zhicheng about some construction principles and status of the early warning and monitoring system. Ms. Ma ChunZi asked Professor Gong Zhicheng about the nature of the early warning and monitoring system. Professor Gong Zhicheng asked Professor Takeda about Japan's assessment principles and measures in talent training. Mr. Ding Yufeng, director of Pharmacy Department of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of science and technology, asked Professor Gong Zhicheng about the method of realizing the interoperability between the data of early warning monitoring system and hospital medical data. Guo, director of Jining first people's Hospital, and representatives of Sichuan Provincial People's Hospital, Western Theater general hospital and other hospitals participated in the discussion.

At the end of the meeting, Professor Takeda Taisheng concluded that in the past, pharmacists carried out work centered on drugs in the hospital, and in the future, pharmacists will mainly serve families in the pharmaceutical Bureau. Therefore, this kind of early warning and monitoring system promoted by Professor Gong Zhicheng is very important and will be widely developed. Professor Zhang Xianglin said that the meaning of "Linghe" is very consistent with the "harmony" advocated by China, and the experience introduced by Japanese experts has a large amount of information and high reference value. Whether it is reasonable and safe infusion, or the development of the work content and form of pharmacists, it is a cause of serving the whole society and mankind. It is inseparable from people of insight all over the world learning from each other and exchanging what they need, It is hoped that with the joint efforts of all sectors of society, China Japan exchange activities will become more rich and mature and serve the society. Huawei pharmaceutical will also continue to adhere to the purpose of "becoming an integrator, sharer and innovator in China's great health field" and make more contributions to the communication field of China Japan pharmaceutical industry.